Why reformulating the flu vaccine is easier said than done

It might seem like reformulating would be as simple as deciding to leave blueberries out of a mixed-fruit smoothie. It turns out it is not.

January 16, 2024 Check out STAT+

Sponsored By

Adobe The WHO and drug regulators want to reformulate the flu vaccine. It's easier said than done Vaccine manufacturers have been urged to drop the component known as B/Yamagata from flu vaccines as quickly as possible. By Helen Branswell STAT+ | The new NIH director is walking a tightrope on Biden's drug pricing vision NIH Director Monica Bertagnolli is at the center of the drug pricing debate over so-called "march-in rights." She's taking a cautious line. By Sarah Owermohle STAT+ | FDA expands approval of CRISPR-based medicine to treat beta thalassemia The expanded approval of the therapy, called Casgevy, was widely expected but came two months ahead of the FDA's decision deadline. By Adam Feuerstein Adobe Opinion: BMI as a barrier to orthopedic surgery doesn't make sense for patient health Why is there a knee jerk response by many orthopedists to deny joint replacement surgery to people above a certain BMI? By Jody Dushay STAT+ | Could private equity be the future of private practice? A new lobbying group thinks so Some doctors see private equity as the only way for their practices to survive — and now, they're taking that message to Washington. By Brittany Trang STAT+ | Survey: Confusion over key requirements means clinical trials aren't registered and results aren't reported Between 25% and 30% of responsible parties are unconcerned with potential consequences for failing to comply with disclosure requirements. By Ed Silverman Adobe STAT+ | Many doctors are in the dark about how FDA approves devices and drugs, survey finds Doctors prescribe medical devices, but a new survey finds that many don't know how the FDA approval process works. By Lizzy Lawrence

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser